A Study of ZT002 Injection With Subjects With Overweight or Obesity

NCT07020884 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: ZT002 Injection
DRUG: ZT002 Placebo

Sponsor

Beijing QL Biopharmaceutical Co.,Ltd